Columbia University
Events Banner
Regeneron Pharmaceuticals, Inc. Info Session

Date:February 27, 2013 from 1:00 pm to 2:00 pm EST
Location:CESPR, 414
Contact:For further information regarding this event, please contact Center For Career Education by sending email to careereducation@columbia.edu .

If you are looking for an uncommon opportunity -- a chance to join an organization known for its scientific excellence in the research and development of pharmaceuticals -- it's time to consider Regeneron.

Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use; ZALTRAP is co-commercialized with Sanofi. Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727. Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.

Target Audience: Undergrads - Sophomores, Juniors, Seniors

Add To My Calendar